{
    "2021-07-15": [
        [
            {
                "time": "2021-07-15",
                "original_text": "港股收盘(7.15)|恒指收涨0.75% 央行释放流动性超预期 内银、内险股集体爆发",
                "features": {
                    "keywords": [
                        "央行",
                        "流动性",
                        "内银",
                        "内险股",
                        "恒指"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "保险"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-16",
                "original_text": "复星医药(02196.HK)：「18复药01」票面利率将调整为3.5%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "债券",
                        "利率",
                        "调整"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-17",
                "original_text": "开拓药业、复星医药就普克鲁胺治疗新冠在印、非等29国商业化达成合作",
                "features": {
                    "keywords": [
                        "开拓药业",
                        "复星医药",
                        "普克鲁胺",
                        "新冠",
                        "商业化"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-07-18",
                "original_text": "解盘：金融拉指数，白酒、保险、光伏屋顶领涨",
                "features": {
                    "keywords": [
                        "金融",
                        "白酒",
                        "保险",
                        "光伏屋顶",
                        "领涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "消费",
                        "能源"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-19",
                "original_text": "mRNA新冠疫苗通过专业评审！复星医药早盘强势上涨近7%，恒生医疗ETF近10天犀利吸金7400万元！",
                "features": {
                    "keywords": [
                        "mRNA",
                        "新冠疫苗",
                        "复星医药",
                        "评审",
                        "上涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "复星医药(02196.HK)涨逾5%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "上涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-21",
                "original_text": "【异动股】复星医药(02196.HK)涨6.02%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "上涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-22",
                "original_text": "港股异动 | 复星医药(02196)涨超7% 报道称mRNA新冠疫苗“复必泰”通过专业评审",
                "features": {
                    "keywords": [
                        "复星医药",
                        "mRNA",
                        "复必泰",
                        "评审",
                        "上涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}